126 related articles for article (PubMed ID: 17888167)
1. Unravelling the hidden heterogeneities of diffuse large B-cell lymphoma based on coupled two-way clustering.
Zhang W; Li L; Li X; Jiang W; Huo J; Wang Y; Lin M; Rao S
BMC Genomics; 2007 Sep; 8():332. PubMed ID: 17888167
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the hidden heterogeneities of breast cancer based on functional miRNA cluster.
Li L; Liu C; Wang F; Miao W; Zhang J; Kang Z; Chen Y; Peng L
PLoS One; 2014; 9(1):e87601. PubMed ID: 24498150
[TBL] [Abstract][Full Text] [Related]
3. Peeling off the hidden genetic heterogeneities of cancers based on disease-relevant functional modules.
Xu JZ; Guo Z; Zhang M; Li X; Li YJ; Rao SQ
Mol Med; 2006; 12(1-3):25-33. PubMed ID: 16838067
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of diffuse large B-cell lymphoma heterogeneity based on coupled two-way clustering].
Li L; Li X; Chen YH; Guo Z; Jiang W; Zhagn RJ; Rao SQ
Yi Chuan; 2006 Sep; 28(9):1129-34. PubMed ID: 16963424
[TBL] [Abstract][Full Text] [Related]
5. Pathway-based analysis of the hidden genetic heterogeneities in cancers.
Zhao X; Zhong S; Zuo X; Lin M; Qin J; Luan Y; Zhang N; Liang Y; Rao S
Genomics Proteomics Bioinformatics; 2014 Feb; 12(1):31-8. PubMed ID: 24462714
[TBL] [Abstract][Full Text] [Related]
6. Pathway analysis of informative genes from microarray data reveals that metabolism and signal transduction genes distinguish different subtypes of lymphomas.
Mircean C; Tabus I; Kobayashi T; Yamaguchi M; Shiku H; Shmulevich I; Zhang W
Int J Oncol; 2004 Mar; 24(3):497-504. PubMed ID: 14767533
[TBL] [Abstract][Full Text] [Related]
7. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.
Wright G; Tan B; Rosenwald A; Hurt EH; Wiestner A; Staudt LM
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9991-6. PubMed ID: 12900505
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signature.
Suguro M; Tagawa H; Kagami Y; Okamoto M; Ohshima K; Shiku H; Morishima Y; Nakamura S; Seto M
Cancer Sci; 2006 Sep; 97(9):868-74. PubMed ID: 16856881
[TBL] [Abstract][Full Text] [Related]
10. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
Rossi D; Gaidano G
Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
[TBL] [Abstract][Full Text] [Related]
11. Microarray gene expression data with linked survival phenotypes: diffuse large-B-cell lymphoma revisited.
Segal MR
Biostatistics; 2006 Apr; 7(2):268-85. PubMed ID: 16284340
[TBL] [Abstract][Full Text] [Related]
12. Iterative class discovery and feature selection using Minimal Spanning Trees.
Varma S; Simon R
BMC Bioinformatics; 2004 Sep; 5():126. PubMed ID: 15355552
[TBL] [Abstract][Full Text] [Related]
13. Microarray-based classification of diffuse large B-cell lymphoma.
Poulsen CB; Borup R; Nielsen FC; Borregaard N; Hansen M; Grønbaek K; Møller MB; Ralfkiaer E
Eur J Haematol; 2005 Jun; 74(6):453-65. PubMed ID: 15876249
[TBL] [Abstract][Full Text] [Related]
14. Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString nCounter System.
Veldman-Jones MH; Lai Z; Wappett M; Harbron CG; Barrett JC; Harrington EA; Thress KS
Clin Cancer Res; 2015 May; 21(10):2367-78. PubMed ID: 25301847
[TBL] [Abstract][Full Text] [Related]
15. Randomized maps for assessing the reliability of patients clusters in DNA microarray data analyses.
Bertoni A; Valentini G
Artif Intell Med; 2006 Jun; 37(2):85-109. PubMed ID: 16720093
[TBL] [Abstract][Full Text] [Related]
16. QuantiGene Plex Represents a Promising Diagnostic Tool for Cell-of-Origin Subtyping of Diffuse Large B-Cell Lymphoma.
Hall JS; Usher S; Byers RJ; Higgins RC; Memon D; Radford JA; Linton KM
J Mol Diagn; 2015 Jul; 17(4):402-11. PubMed ID: 25982535
[TBL] [Abstract][Full Text] [Related]
17. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F
Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118
[TBL] [Abstract][Full Text] [Related]
18. [Gene expression profiling of diffuse large B-cell lymphoma in China].
Liu YH; Li L; Liu G; Zhuang HG; Luo DL; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):79-83. PubMed ID: 17493379
[TBL] [Abstract][Full Text] [Related]
19. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
[TBL] [Abstract][Full Text] [Related]
20. Machine-learning-based classification of diffuse large B-cell lymphoma patients by a 7-mRNA signature enriched with immune infiltration and cell cycle.
Zhuang X; Liu B; Long J; Wang H; Yu J; Ji X; Li J; Zhu N; Li L; Chen Y; Liu Z; Zhao S
Clin Transl Oncol; 2024 Apr; 26(4):936-950. PubMed ID: 37783922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
